Filing Details
- Accession Number:
- 0001651308-21-000128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 16:49:03
- Reporting Period:
- 2021-06-16
- Accepted Time:
- 2021-06-21 16:49:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 981209416 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739452 | Xiaobin Wu | C/O Mourant Governance Services (Cayman) 94 Solaris Avenue Camana Bay, Grand Cayman E9 KY1-1108 | President, Coo & Gm China | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-06-16 | 78,000 | $0.00 | 1,213,729 | No | 4 | A | Direct | |
| American Depositary Shares | Disposition | 2021-06-18 | 1,156 | $330.93 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Share Option (Right to Buy) | Acquisiton | 2021-06-16 | 483,678 | $0.00 | 483,678 | $26.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 483,678 | 2031-06-15 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| American Depositary Shares | 12,365 | Direct | |
| American Depositary Shares | 4,000 | Indirect | By Wife |
Footnotes
- Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vestingupon certain termination events following a change in control.
- Each American Depositary Share represents 13 Ordinary Shares.
- The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.9148 to $331.045, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares sold at each separate price.
- The number of securities underlying the option and the exercise price therefor are represented in ordinary shares.
- These securities vest over a four-year period as follows: 25% on June 16, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject toaccelerated vesting upon certain termination events following a change in control.
Billionaire Hedge Funds
